Facebook Pixel Code
About Sickkids
About SickKids

Ian Kitai, MB, BCh, FRCP(C)

The Hospital for Sick Children
Staff Physician, TB Specialist
Infectious Diseases

University of Toronto
Professor
Paediatrics

Other Positions

Lakeridge Health, Ajax Community Practice
Pediatrics and Infectious Diseases


Phone: 416-813-7654 x201985
Email: ian.kitai@sickkids.ca

Brief Biography

Dr. Kitai trained in Medicine in South Africa, in Paediatrics in the U.K. and Toronto and in Paediatric Infectious Diseases in Toronto. He has worked for three years for Oxfam (U.K.) in rural Zimbabwe and for two years with the Northern Medical Unit of the University of Manitoba. He is currently in consulting paediatric practice in Ajax and is the TB specialist at The Hospital for Sick Children (SickKids) in Toronto. From 2002 to 2006 he was a medical consultant in Infection Control at the Rouge Valley Health System and received the Council award from the College of Physicians and Surgeons of Ontario partly for his work during SARS.

Clinical Care Activities

Paediatric tuberculosis, paediatric infectious diseases and general paediatrics.

Academic Background

MB, BCh, FRCP(C)

Research Interests

Diagnosis and management of paediatric tuberculosis. 

  • Clinical presentation of paediatric TB at different ages
  • Epidemiology of pediatric TB in Canada
  • Diagnostic tests for pediatric TB
  • Utility of Canadian TB Medical Surveillence of migrant children and adolescents.

Diagnosis and management of paediatric infectious disease in a community setting.

Achievements

2004 - College of Physicians and Surgeons of Ontario Council Award

1991 - The Hospital for Sick Children, Toronto

Odaantjie foundation award for excellence in clinical teaching

Second prize, Tisdall award for excellence in paediatric research

Publications

Select recent publications

  1. Kordy F, Waters V, Den Hollander C, Read S, Lam R, Kitai I. Optimizing blood collection and processing for QuantiFERON-TB Gold-In Tube testing gives low rates of indeterminate results: clinical implications. Pediatr Infect Dis J. 2018 Jan;37(1):e22-e24.
  2. Kitai I, Kordy M, Morris S, Lam R.  Diagnosis and management of paediatric tuberculosis in Canada.  CMAJ 2017 January 9;189:E11-6.
  3. Xu  J, Peer S, Papsin B, Kitai I,. Propst EJ.   Tuberculous lymphadenitis of the head and neck in Canadian children: experience from a low-burden region. International Journal of Pediatric Otorhinolaryngology 2016 91:11-14.
  4. *Rayment J, Guthrie JL. Lee B, Whelan M, Lam K, Jamieson F, Kitai I.  Culture-positive paediatric tuberculosis in Toronto, Ontario: Sources of infection and relationship of birthplace and mycobacterial lineage to phenotype. Pediatr Infect Dis J 2016 Jan: 35:13-8.
  5. Rose W, Read S, Bitnun A, Rea E, Stephens D, Pongsamart W, Kitai I. Relating tuberculosis (TB) contact characteristics to QuantiFERON-TB-Gold and tuberculin skin test results in the Toronto pediatric TB clinic.  J Pediatric Infect Dis Soc. 2015 :96-103.
  6. Khan S, Stimec J, Kitai I. Non responding osteomyelitis in a two-year-old boy. Practice, CMAJ. 2015;187:901-4
  7. Morris SK, Demers AM, Lam R, Pell LG, *Giroux R, Kitai I. Epidemiology and clinical management of tuberculosis in children in Canada. Paediatr Child Health. 2015 20: 83-8.
  8. Kordy F, Richardson SE, Stephens D, Lam R, Jamieson F, Kitai I. Utility of Gastric Aspirates for Diagnosing Tuberculosis in Children in a Low Prevalence Area: Predictors of Positive Cultures and Significance of Non-Tuberculous Mycobacteria.Pediatr Infect Dis J. 2015 Jan;34(1):91-3.
  9. Rose W, Kitai I *Kakkar F, Read S, Bitnun A.  Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values. BMC Infectious Diseases 2014, 14:516  doi:10.1186/1471-2334-14-516.
  10. Hildebrand K, Atkinson A, Kitai I. Rifampin hypersensitivity in a two-year old child with successful rapid oral desensitization. Pediatr Infect Dis J. 2014 Jul;33(7):787
  11. Kitai I, Morris SK: Encounters with an old foe: Childhood tuberculosis in Canada.  Pediatr Child Health  2014; 89-90.
  12. Kitai I.  Demers AM. Paediatric Tuberculosis.  in Menzies D (ed) Canadian TB Standards, 7th Edition, Public Health Agency of Canada and Canadian Thoracic Society. Prerelease available at http://www.respiratoryguidelines.ca/tb-standards-2013 Canadian Respiratory Journal July/August 2013, Volume 20, Supplement SA     
  13. Science M, Ito S, Kitai I. 1. Isoniazid toxicity in a 5 year old boy. Practice: CMAJ. 2013;185: 894-6
  14. Schwartz K, Al-Rasheed A, Laxer R, Lam R, Kitai I. Monoarthritis in a four year old child. Paediatr Child Health 2012 17: 387-90.
  15. Thampi N, Stephens D, Rea E, Kitai I. Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors. Pediatr Infect Dis J. 2012 31:129-33.
  16. Greenaway C, Sandoe A, Vissandjee B, Kitai I, et al.  Tuberculosis: evidence review for newly arriving immigrants and refugees.   CMAJ. 2011: 183 E824-925.
  17. Al-Dabbagh M, Lapprha K, Pattar R, Inrig K, Sauve L, Simon Schaaf H, Marais BJ,  Kitai I and Kollmann TR. Drug-Resistant Tuberculosis: A Review of Pediatric Treatment Guidelines.  Pediatr Infect Dis J. 2011 30:501-505.
  18. Kakkar F, Ling D, Pai M, Allen U,  Kitai I (for the Canadian Pediatric Society) Tuberculosis in Children: new diagnostic blood tests. Paediatr Child Health 2010;15(8):529-33.
  19. Pau WS, AlSaffar H, Weinstein M, Kitai I. Sporotrichoid-like tuberculosis.  Pediatr Infect Dis J. 2009 28:1135-6.  
  20. Phongsamart W,  Kitai I,  Gardam M,  Wang J,  Khan K N. A population-based study of tuberculosis in children and adolescents in Ontario.  Pediatr Infect Dis J 2009; 28:416-9.